You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 112 No. 5, May 1994 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Sciences
 This Article
 •References
 •Full text PDF
 •Correction
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (19)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Calcific Band Keratopathy Associated With the Use of Topical Steroid-Phosphate Preparations

Michael J. Taravella, MD; R. Doyle Stulting, MD, PhD; Thomas H. Mader, MD; Robert W. Weisenthal, MD; S. Lance Forstot, MD; Larry D. Underwood, MD

Arch Ophthalmol. 1994;112(5):608-613.


Abstract

Objective
To report a possible adverse effect of topical steroid-phosphate preparations and to identify factors that may contribute to the development of this effect.

Design
The medical records of five patients who developed calcium deposition in the cornea were reviewed and analyzed for possible contributing factors.

Patients
Five cases of calcium deposition in the cornea associated with the use of topical steroid-phosphate preparations are described. Scrapings from the cornea and/or specimens obtained at keratoplasty were available in all cases. These cases had the following characteristics in common: use of steroidphosphate preparations (n=5); multiple topical drops (n=5); penetrating keratoplasty (n=3); presence of epithelial defects (n=4); history of herpetic stromal keratitis (n=4); and history of iritis (n=3). A hypothesis explaining calcium deposition in association with steroid-phosphate preparations is presented.

Conclusions
We recommend withdrawal of steroidphosphate preparations in patients who develop band keratopathy.



Author Affiliations

From the Department of Ophthalmology, University of Colorado School of Medicine, Denver (Drs Taravella, Forstot, and Underwood); the Department of Ophthalmology, Emory University, Atlanta, Ga (Dr Stulting); Madigan Army Medical Center, Tacoma, Wash (Dr Mader); and Syracuse (NY) Eye Center (Dr Weisenthal). The authors have no proprietary interest in any drugs mentioned in this article.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Phosphate and electrolyte content of topical steroid drops and potential clinical implications
Mukherjee et al.
Br J Ophthalmol 2008;92:574-576.
FULL TEXT  

Corneal Stromal Calcification After Topical Steroid-Phosphate Therapy
Schlotzer-Schrehardt et al.
Arch Ophthalmol 1999;117:1414-1418.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.